Literature DB >> 10371383

Periventricular leukomalacia: relation to gestational age and axonal injury.

K Deguchi1, K Oguchi, N Matsuura, D D Armstrong, S Takashima.   

Abstract

Eighty-five infants ranging from 22 to 41 weeks gestation were diagnosed as having periventricular leukomalacia (PVL) using traditional neuropathologic methods. The lesions were also studied by immunocytochemistry for beta-amyloid precursor protein (beta-APP), a glycoprotein that has been observed in PVL. Using this technique, the distribution of white matter tissue necrosis was defined as focal, widespread, and diffuse. The type of PVL correlated with the gestational age at birth. The youngest infants tended to demonstrate widespread necrosis, and the oldest infants exhibited more focal necrosis. beta-APP immunopositivity was present in the axons around the foci of white matter necrosis in 76% of the patients and in the neurons of the adjacent cortex in 66% of the patients. In age-matched control patients, there was no beta-APP reactivity in the cerebral white matter or the cortex. In most patients the distribution of beta-APP-positive axons proved to be a useful marker for demonstrating the type of PVL; however, the relationship of beta-APP to the pathogenesis of PVL requires further study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371383     DOI: 10.1016/s0887-8994(99)00010-7

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  15 in total

Review 1.  Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.

Authors:  Joseph J Volpe
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

Review 2.  Neonatal brain hemorrhage (NBH) of prematurity: translational mechanisms of the vascular-neural network.

Authors:  Tim Lekic; Damon Klebe; Roy Poblete; Paul R Krafft; William B Rolland; Jiping Tang; John H Zhang
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Melatonin ameliorates brain injury induced by systemic lipopolysaccharide in neonatal rats.

Authors:  C-S Wong; G-M Jow; A Kaizaki; L-W Fan; L-T Tien
Journal:  Neuroscience       Date:  2014-03-05       Impact factor: 3.590

4.  Ocular signs, visual and general developmental outcome in Indian children with radiologically proven periventricular leukomalacia.

Authors:  Perumalsamy Vijayalakshmi; Jeyaseeli Flora; Gargi Shah; Bhaskaran Sahithya; Clare Gilbert
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 1.848

Review 5.  Molecular mechanisms involved in injury to the preterm brain.

Authors:  Angela M Kaindl; Géraldine Favrais; Pierre Gressens
Journal:  J Child Neurol       Date:  2009-07-15       Impact factor: 1.987

Review 6.  The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.

Authors:  Joseph J Volpe
Journal:  Semin Pediatr Neurol       Date:  2009-12       Impact factor: 1.636

7.  alpha-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced brain injury and improves neurological reflexes and early sensorimotor behavioral performance in juvenile rats.

Authors:  Lir-Wan Fan; Ruei-Feng Chen; Helen J Mitchell; Rick C S Lin; Kimberly L Simpson; Philip G Rhodes; Zhengwei Cai
Journal:  J Neurosci Res       Date:  2008-12       Impact factor: 4.164

8.  Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin.

Authors:  Robin L Haynes; Saraid S Billiards; Natalia S Borenstein; Joseph J Volpe; Hannah C Kinney
Journal:  Pediatr Res       Date:  2008-06       Impact factor: 3.756

9.  Alpha-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced neuronal injury in the neonatal rat brain.

Authors:  L-W Fan; H J Mitchell; P G Rhodes; Z Cai
Journal:  Neuroscience       Date:  2007-11-29       Impact factor: 3.590

10.  Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide.

Authors:  Asuka Kaizaki; Lu-Tai Tien; Yi Pang; Zhengwei Cai; Sachiko Tanaka; Satoshi Numazawa; Abhay J Bhatt; Lir-Wan Fan
Journal:  J Neuroinflammation       Date:  2013-04-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.